Identification of potential JNK3 inhibitors through virtual screening, molecular docking and molecular dynamics simulation as therapeutics for Alzheimer’s disease-Reference-Cited by-同舟云学术

Identification of potential JNK3 inhibitors through virtual screening, molecular docking and molecular dynamics simulation as therapeutics for Alzheimer’s disease

Published:2024-04-04 Issue: Volume: Page:
ISSN:1381-1991
Container-title:Molecular Diversity
language:en
Short-container-title:Mol Divers

Author:

Devi Bharti,Jangid Kailash,Kumar Naveen,Kumar Vinay,Kumar Vinod^ORCID

Funder

Indian Council of Medical Research

Council of Scientific and Industrial Research, India

MoE STARS, IISc Bangolre

Publisher

Springer Science and Business Media LLC

Link

https://link.springer.com/content/pdf/10.1007/s11030-024-10820-0.pdf

Reference63 articles.

1. Lisnock J, Griffin P, Calaycay J, Frantz B, Parsons J, O’Keefe SJ, LoGrasso P (2000) Activation of JNK3 alpha 1 requires both MKK4 and MKK7: kinetic characterization of in vitro phosphorylated JNK3 alpha 1. Biochemistry 39(11):3141–3148

2. Wada T, Penninger JM (2004) Stress kinase MKK7: saviour of cell cycle arrest and cellular senescence. Cell Cycle 3(5):575–577

3. Fleming Y, Armstrong CG, Morrice N, Paterson A, Goedert M, Cohen P (2000) Synergistic activation of stress-activated protein kinase 1/c-Jun N-terminal kinase (SAPK1/JNK) isoforms by mitogen-activated protein kinase kinase 4 (MKK4) and MKK7. Biochem J 352:145–154

4. Kant S, Craige SM, Chen K, Reif MM, Learnard H, Kelly M, Caliz AD, Tran K-V, Ramo K, Peters OM, Freeman M, Davis RJ, Keaney JF (2019) Neural JNK3 regulates blood flow recovery after hindlimb ischemia in mice via an Egr1/Creb1 axis. Nat Commun 10(1):4223

5. Yarza R, Vela S, Solas M, Ramirez MJ (2016) c-Jun N-terminal kinase (JNK) signaling as a therapeutic target for Alzheimer’s disease. Front Pharmacol 6:321

Cited by 1 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Phenylstyrylpyrimidine derivatives as potential multipotent therapeutics for Alzheimer's disease;RSC Medicinal Chemistry;2024